Streetbeat News

Stock Prices

DRIO

DarioHealth Corp. has acquired Twill, aiming to enhance its digital offerings for chronic conditions. The acquisition, valued at $10M in cash plus around 10M pre-funded warrants in shares, is expected to nearly double Dario's pro forma revenues in 2023. This strategic move is immediately accretive to revenue and gross margins, and is anticipated to accelerate Dario's path to profitability.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 11:04 am

LIVN

LivaNova reported Q4 adjusted EPS of $0.87, surpassing the $0.77 estimate, and sales of $310.10M, exceeding the $287.39M estimate. This represents a 7.41% increase in earnings and a 12.80% increase in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 11:02 am

DOGEUSD

XRPUSD

Ripple CEO Brad Garlinghouse expressed openness to backing an XRP-focused ETF during a Bloomberg interview. He refrained from commenting on discussions with asset managers like BlackRock, following speculation about BlackRock's interest in an XRP ETF, which was later discredited. Garlinghouse criticized the SEC's approach under Gary Gensler and expressed skepticism about the utility of Dogecoin. XRP's price was reported to be down 3.60% at $0.54.

Portfolio Pulse from Mehab Qureshi

February 21, 2024 | 11:02 am

UTHR

United Therapeutics (NASDAQ:UTHR) reported Q4 GAAP EPS of $4.36, surpassing the $4.19 estimate, marking a 63.3% increase from last year. Sales reached $614.70M, exceeding the $575.87M estimate, a 25.07% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 11:01 am

VRT

Vertiv Holdings projects Q1 revenue to be between $1.575B and $1.625B, slightly below the estimated $1.62B. The adjusted EPS is expected to be $0.32-$0.36, under the $0.37 estimate.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 11:00 am

LQDA

UTHR

United Therapeutics has initiated legal action against the FDA for denying its right to delay Liquidia's final approval until its patent infringement claim against Liquidia is resolved. This move underscores a significant patent dispute between United Therapeutics and Liquidia, potentially impacting the market's view on both companies' stock.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 10:59 am

VRT

Vertiv Holdings (VRT) reported Q4 adjusted EPS of $0.56, surpassing the $0.53 estimate, marking a 100% increase from last year's $0.28. However, its $1.86B sales fell short of the $1.88B estimate, despite being a 12.69% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 10:57 am

SHOO

Williams Trading analyst Sam Poser downgraded Steven Madden (NASDAQ:SHOO) from Buy to Hold and set a $44 price target.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 10:57 am

NKLA

Nikola Corp's (NASDAQ:NKLA) Badger electric pickup, previously discontinued, is making a comeback through an acquisition by David Sparks, who has ties to Nikola's former CEO Trevor Milton. Sparks, a YouTuber and co-star of Diesel Brothers, has acquired the Badger's vehicle program and intellectual property, planning to reintroduce the vehicles to the market with Nikola as a minority partner. This development follows a tumultuous period for Nikola, involving scandals and a significant valuation drop, raising questions about the future of the Badger and its impact on Nikola.

Portfolio Pulse from Benzinga Neuro

February 21, 2024 | 10:53 am

WIX

Wix.Com's shares are trading lower despite the company reporting Q4 financial results and issuing FY24 guidance that exceeded estimates.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 10:34 am